Severe nosocomial infections due to Enterobacter taylorae (formerly known as CDC Enteric Group 19) are described in four patients. Unlike most members of the Enterobacter genus, the isolates were not susceptible to penicillins or cephalosporins. Restriction endonuclease analysis of E. taylorae DNA obtained from three patients identified two distinct strains. One strain was found in two patients, suggesting a common source which we were not able to identify. We postulate that in patients harboring E. taylorae, the combination of cephalosporin therapy and instrumentation enables this organism to become an opportunistic pathogen.
ASJC Scopus subject areas
- Microbiology (medical)